About
Germany's medical technology market is projected to reach a revenue of approximately USD 40.37 billion by 2025. The largest segment within this market is medical devices, which is expected to generate a revenue of USD 36.43 billion during the same year.
Germany's health science and medical technology sector is substantial and continues to grow, boasting strong growth prospects and a significant share of the European market. The German medical device market is particularly lucrative, generating around USD 42 billion annually, accounting for about 25% of the European market. Key trends driving this growth include digitalization, individualized patient-centered care, and the integration of artificial intelligence and digital solutions.
Germany holds the largest share of the European medical technology market, with sales estimated at around EUR 43 billion in 2023, representing nearly 27% of the market, according to GTAI – Invest in Germany. Germany is recognized as a hub for medical technology innovation, with a strong emphasis on research and development. This commitment leads to the creation of innovative products and improved patient outcomes.
| 1H25 interim dividend per ordinary share: | $A2.60 per share (35% franked) |
|---|---|
| Ex-dividend date: | 11 November 2024 |
| Record date: | 12 November 2024 |
| Payment date: | 17 December 2024 |
|
DRP allocation price: |
To be sourced on-market1 |
Germany's medical technology market is anticipated to reach USD 40.37 billion by 2025, with the medical devices segment leading at USD 36.43 billion. The market is expected to grow at an annual rate of 4.48% (CAGR 2025-2029), potentially reaching USD 48.11 billion by 2029. Prominent trends in the German medical technology sector include digitalization, the application of artificial intelligence, and the advancement of digital healthcare solutions.
Case study
Innovative Medical Devices Transforming Patient Care in Germany
Case study
Regional Strengths of Germany’s Medical Technology Sector
Case study
The Rise of Digital Health Solutions in German Healthcare
| Dividend | Dividends per fully paid ordinary share (AU cents) | Franked amount | Applicable tax rate for franked amounts | Record date (dd/mm/yy) | Payment date (dd/mm/yy) |
|---|---|---|---|---|---|
| 04/05 Special | 40 | 90% | 30% | 27/05/2020 | 01/07/2020 |
| 02/03 Special | 50 | 100% | 30% | 23/05/2022 | 02/07/2022 |
On 12 December 2013, GTS GmbH shareholders approved the distribution to eligible shareholders of one stapled security Sydney Airport (SYD) for each Macquarie ordinary share held. The distribution was apportioned between a capital return and a special dividend based on a split of 69% and 31%, respectively. The record date for the entitlement to the SYD distribution was 20 December 2013.
The distribution was calculated at the SYD closing share price of $A3.73 on 10 January 2014 and the two components included:
Following the distribution, GTS GmbH shareholders were required to perform a share consolidation on a 0.9438 for one basis to adjust for the capital reduction.
Please refer to Section 5 of the Notice of Meeting for further information on the tax implication following the Sydney Airport distribution.
Have a question about the recruitment process or working at GTS GmbH?
